Latest News Archive
Please select Category, Year, and then Month to display items
25 September 2024
|
Story Jacky Tshokwe
|
Photo Supplied
Prof Louise Cilliers, University of the Free State (UFS) research fellow and former head of the Department of Classical Studies.
Prof Louise Cilliers, one of our esteemed research fellows and former head of the Department of Classical Studies, has been awarded the prestigious 2024 UJ Translation Prize. Prof Cilliers received this accolade for her exceptional Afrikaans translation of the renowned Greek poet Konstantinos Kavafis' poetry collection, Van Alexandrië na Ithaka, published by Naledi.
Konstantinos Kavafis (1863-1933) is considered one of the most important literary figures in modern Greek poetry, known for his reflective and often philosophical poems that explore themes of history, identity, and human experience. In Van Alexandrië na Ithaka, Prof Cilliers brings the essence of Kavafis’ work to Afrikaans readers, carefully preserving the poet’s rich symbolism, historical depth, and emotional nuances.
Prof Cilliers has had a distinguished academic career, having served as head of the Department of Classical Studies. Her expertise in classical languages and literature, coupled with her passion for translation, made her an instrumental figure in making classical texts more accessible to a broader audience. This award is not only a testament to her scholarly achievements, but also to her dedication to the cultural and literary enrichment of the Afrikaans language.
The UJ Prize for Translation honours outstanding translations of literary works into any of South Africa’s official languages. Prof Cilliers' recognition continues the department's proud tradition of excellence in classical scholarship and language studies.
We extend our heartfelt congratulations to Prof Cilliers for this remarkable achievement and are excited to celebrate her continued contributions to the field of classical studies and translation.
About the UJ Translation Prize
The University of Johannesburg Translation Prize celebrates the best translations of literary works into any of South Africa’s official languages. It aims to promote high standards of literary translation and showcase the importance of bringing international literary voices into the local context through translation.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004